Abstract
Implantable monolithic and reservoir-like water-swellable drainage devices were developed for the subconjunctival sustained release of 5-fluorouracil (5-FU) in glaucoma-filtering surgery. A water-swellable matrix was formed of a copolymer of 2-hydroxyethyl methacrylate with different amounts of ethylene glycol dimethacrylate. Drug incorporation was done before polymerization and cross-linking. Release of 5-FU from these implants was studied in vitro. The rate of drug release was controlled by changing the drug loading, crosslinking density of polymer matrix and type of implantable device.
| Original language | English |
|---|---|
| Pages (from-to) | 941-949 |
| Number of pages | 9 |
| Journal | Biomaterials |
| Volume | 17 |
| Issue number | 9 |
| DOIs | |
| Publication status | Published - May 1996 |
Keywords
- 5-fluorouracil
- Drainage device
- Glaucoma
- Sustained release
- pHEMA
Fingerprint
Dive into the research topics of '5-FU loaded pHEMA drainage implants for glaucoma-filtering surgery: Device design and in vitro release kinetics'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver